Arcus Biosciences, Inc.·4

Jan 27, 4:30 PM ET

Ribas Antoni 4

4 · Arcus Biosciences, Inc. · Filed Jan 27, 2025

Insider Transaction Report

Form 4
Period: 2025-01-23
Ribas Antoni
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-23+5,0005,000 total
    Exercise: $13.33Exp: 2035-01-22Common Stock (5,000 underlying)
Holdings
  • Common Stock

    30,350
  • Common Stock

    (indirect: By Trust)
    8,553
Footnotes (1)
  • [F1]The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.

Documents

1 file
  • 4
    wk-form4_1738013435.xmlPrimary

    FORM 4